Lindsay Singler, MPH, is the DCRI’s Associate Chief Operating Officer, where she ensures consistency, efficiency, and collaboration among the organization's Research Communications & Engagement, CEC/Safety/Imaging (CSI+), Biostatistics, Data Solutions, and Clinical Trials Transformation Initiative teams.

Singler joined the DCRI in 2016 as Associate Director of Research Communications & Engagement before being named Director in 2021. She led patient and site communications for DCRI-led programs and studies, overseeing a health communications team serving industry and government research sponsors. Her work included defining communication strategy for prominent programs such as the NIH Environmental influences on Child Health Outcomes (ECHO) Program and the FDA Global Pediatric Trials Network. She also led the DCRI's decentralized clinical trial offering team and served as project leader for the organization's first direct-to-family pediatric lupus study, iPERSONAL. A co-founder of the DCRI's Research Together initiative, Singler has been a champion for patient-centered research, forming effective partnerships between patients, caregivers, and researchers to deliver more inclusive and impactful studies.

Prior to joining the DCRI, Singler held several leadership positions at Quintiles (now IQVIA), including Director of Health Engagement & Communication and Associate Director of Corporate Communications. Earlier in her career, she held account leadership roles at Ogilvy and Fusion Public Relations.

Singler holds a Bachelor of Arts in Communication with a concentration in Public Relations from North Carolina State University and a Master of Public Health with a concentration in Public Health Leadership from the UNC Gillings School of Global Public Health at the University of North Carolina at Chapel Hill.